TRCT
BNGO icon

Tower Research Capital (TRC)’s Bionano Genomics BNGO Stock Holding History

Tower Research Capital (TRC)’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.91K Buy
+5,228
New +$6.3K ﹤0.01% 4247
2026
Q1 		– Sell
-3,546
Closed -$5.42K – 5142
2025
Q4 		$5.42K Buy
3,546
+3,521
+14,084% +$6.09K ﹤0.01% 4126
2025
Q3 		$43 Sell
25
-2,283
-99% -$7.26K ﹤0.01% 5154
2025
Q2 		$7.57K Buy
+2,308
New +$8.61K ﹤0.01% 4048
2025
Q1 		– Sell
-286
Closed -$4.95K – 5221
2024
Q4 		$4.95K Buy
286
+2
+0.7% +$34 ﹤0.01% 4371
2024
Q3 		$7.73K Sell
284
-146
-34% -$4.54K ﹤0.01% 4021
2024
Q2 		$17.5K Buy
430
+419
+3,809% +$23K ﹤0.01% 3835
2024
Q1 		$737 Sell
11
-7
-39% -$522 ﹤0.01% 5394
2023
Q4 		$2.02K Buy
18
+9
+100% +$940 ﹤0.01% 5289
2023
Q3 		$1.71K Sell
9
-46
-84% -$12.1K ﹤0.01% 5279
2023
Q2 		$20.3K Buy
55
+16
+41% +$7.22K ﹤0.01% 3371
2023
Q1 		$26K Sell
39
-15
-28% -$13.3K ﹤0.01% 3143
2022
Q4 		$47K Sell
54
-1
-2% -$1.26K ﹤0.01% 2389
2022
Q3 		$61K Buy
55
+29
+112% +$38.3K ﹤0.01% 2980
2022
Q2 		$21K Buy
26
+17
+189% +$17.5K ﹤0.01% 3725
2022
Q1 		$14K Sell
9
-6
-40% -$8.1K ﹤0.01% 3870
2021
Q4 		$28K Sell
15
-43
-74% -$115K ﹤0.01% 3291
2021
Q3 		$191K Buy
58
+45
+346% +$157K ﹤0.01% 1861
2021
Q2 		$55K Sell
13
-50
-79% -$197K ﹤0.01% 2943
2021
Q1 		$306K Buy
+63
New +$355K 0.01% 1655
2020
Q3 		– Sell
-68
Closed -$21K – 4820
2020
Q2 		$21K Buy
+68
New +$17.1K ﹤0.01% 3645
2018
Q4 		– Hold
0
– – – 3831
2018
Q3 		– Hold
0
– – – 3774

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Tower Research Capital (TRC)'s BNGO Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Bionano Genomics (BNGO) in Q2 2026: 5,228 shares worth $5.91K. The stake represents ﹤0.01% of the portfolio and ranks #4247 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in BNGO as recently as Q4 2025.

Tower Research Capital (TRC) first reported a position in BNGO in Q2 2020 and has held it in 21 quarters since. The position peaked at $306K in Q1 2021. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

  • Tower Research Capital (TRC) held 5,228 shares of Bionano Genomics worth $5.91K as of Q2 2026.
  • Bionano Genomics was a new Tower Research Capital (TRC) position in Q2 2026.
  • Bionano Genomics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4247 holding.
  • Tower Research Capital (TRC) first reported a position in Bionano Genomics in Q2 2020 and has held it in 21 quarters since.
  • Tower Research Capital (TRC)'s Bionano Genomics position peaked at $306K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.